Akanda Corp AKAN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $9.57
- Day Range
- $8.51–9.29
- 52-Week Range
- $2.33–208.58
- Bid/Ask
- $0.00 / $0.00
- Shares Outstanding
- 540,841.00
- Market Cap
- $4.97M
- Volume/Avg
- 7,953 / 2M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.11
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Akanda Corp is a cannabis cultivation, manufacturing, and distribution company. The company is a medical cannabis & hemp and wellness platform company seeking to help people lives through improved access to high-quality and affordable products. The Company is also in the business of leasing fiber optic networks and telecommunication towers, through its subsidiary. The company has four reportable segments: Infrastructure, Cultivation, Distribution, and Corporate. A majority of its revenue is generated from the Infrastructure segment, which relates to the leasing and/or rental of fiber optic networks and telecommunication towers at First Towers in Mexico.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 6
- Website
- https://www.akandacorp.com
Valuation
|
Metric
|
AKAN
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 0.11 |
Price/Cash Flow | — |
Price/Earnings
AKAN
Financial Strength
|
Metric
|
AKAN
|
|---|---|
Quick Ratio | 0.31 |
Current Ratio | 0.58 |
Interest Coverage | −50.20 |
Quick Ratio
AKAN
Profitability
|
Metric
|
AKAN
|
|---|---|
Return on Assets (Normalized) | 574.04% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | 1,130.30% |
Return on Assets
AKAN
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|RPGXx>W | LOCK|<^Z!? | $69B | |||
| Haleon PLC ADR
HLN
| LOCK|Nx%Cq>r | LOCK|>&Y | $44B | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| LOCK|k#Fyr!M | LOCK|GR<> | $38B | |||
| Zoetis Inc Class A
ZTS
| LOCK|cQRzfx$ | LOCK|H# | $32B | |||
| Viatris Inc
VTRS
| LOCK|!^B&%r% | LOCK|r!> | $20B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|#^ | LOCK|zH$ | $13B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|@$Z#!$ | LOCK|#b | $10B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|!x&s>Xv | LOCK|!d | $8B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|<b&Q<ht | LOCK|>v#Y& | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|wS^lqkb | LOCK|!& | $1B |
United States